National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 331 cases where Vaccine is HPV4 and Symptom is Death

Case Details

This is page 32 out of 34

Result pages: prev   23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 776774 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Injury, Pain
SMQs:, Accidents and injuries (narrow), Hostility/aggression (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: JP0095075131810JPN000947J

Write-up: This spontaneous report as received from a other non-medical expert refers to female patients. On an unknown date, the patient was vaccinated with GARDASIL, intramuscular (inoculation volume, lot number and the date of inoculation had not been reported). On an unknown date, severe chronic generalized pain, deaths and injuries developed. On an unknown date, patients died. The cause of death and presence/absence of an autopsy were unknown. At the time of report, the outcome of severe chronic generalized pain, deaths and injuries was unknown. Reporter''s comment: not reported. The other non-medical expert thought that severe chronic generalized pain was serious due to medically significant and not asessed the seriousness of the adverse event. The other non-medical expert did not assess the relationship betweent severe chronic generalized pain, deaths, adverse event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine. Reported Cause(s) of Death: Death.


VAERS ID: 779627 (history)  
Form: Version 2.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2016-09-12
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Brain neoplasm, Death, Facial paralysis, Headache
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Hearing impairment (broad), Non-haematological tumours of unspecified malignancy (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2017-11-15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FR0095075131810FRA007760

Write-up: This spontaneous report was received from a patient''s relative and refers to a 13 year old female patient. No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. On 12-SEP-2016, the patient was vaccinated with her first dose of GARDASIL (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unspecified date in 2016, (reported as "few days following the injection"), the patient experienced daily headaches and on 29-OCT-2016, the patient presented with facial paralysis on one side of her head. Subsequently on 17-DEC-2016, (reported as "on 17 or 19 December 2016"), a magnetic resonance imaging (MRI) was performed and the patient was diagnosed with a brainstem tumor. On 15-NOV-2017, the patient died from her brainstem tumor. It was unknown whether an autopsy had been performed or not. The reporter did not consider that the patient''s brainstem tumor and subsequent death was related to GARDASIL. Upon internal review, the patient''s brainstem tumor was determined to be a medically significant event. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the GARSASIL vaccine and the reported event brain neoplasm cannot be established. Information regarding prior neurological symptoms, concurrent conditions, medical history, concomitant medications is limited and would be relevant for the case. Company Comment- No changes to the GARDASIL product safety information are warranted at this time. Merck and Co., Inc., known as MSD outside of two countries, continues to monitor the safety profile of the product. Reported Cause(s) of Death: brainstem tumor.


VAERS ID: 783202 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Cervix carcinoma, Death
SMQs:, Uterine and fallopian tube malignant tumours (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FR0095075131810FRA013225

Write-up: This spontaneous report was received from a physician via a lay press article concerning a female patient of unknown age who was reported to be an rowing champion. The report was also identified on the website of the physician in an article. Letter to the parliamentarians". The patient''s pertinent medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patient was vaccinated with GARDASIL (lot#, expiry, dose, frequency and route of administration unknown) for prophylaxis. On an unknown date, the patient died at 33 years of age from cervical cancer (cervix carcinoma). It was unknown if autopsy was performed. The reporter''s causality assessment was not provided. Upon internal review, the event cervix carcinoma was determined to be medically significant. Reported Cause(s) of Death: The patient who was an champion of rowing died at 33 years from cervical cancer after being vaccinated.


VAERS ID: 783274 (history)  
Form: Version 2.0  
Age: 23.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Cervix carcinoma, Death
SMQs:, Uterine and fallopian tube malignant tumours (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2018-07-29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AU0095075131810AUS011861

Write-up: Information was received from an publication and an online article. On an unknown date when the female patient was 23 years old, she received the GARDASIL (lot number, dosage and route of administration not provided). No information was provided concerning the patient''s past medical history, concurrent conditions, or concomitant medication. The patient was diagnosed with cervical cancer when she was 30 years old. The patient and her family "fought for years against a terminal diagnosis." The patient shared her story before she passed away on 29-JUL-2018 and had stated that she felt very passionately about spreading the word on the destruction that GARDASIL could cause. It is unknown if an autopsy was performed. The event of cervical cancer was considered to be related to GARDASIL. Upon internal review, cervical cancer was determined to be medically significant. Additional information is not expected. Reported Cause(s) of Death: Cervical cancer.


VAERS ID: 785465 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CA0095075131811CAN003700

Write-up: This spontaneous report was received from a physician, via a company representative, and refers to a female patient of unknown age. No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. On an unknown date, (reported as "several years ago"), the patient was vaccinated with GARDASIL (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unknown date, the patient died. The cause was unknown, as well as, if an autopsy was performed or not. It was stated that the reporter was looking for more information and whether the patient had any underlying conditions. The causal relationship between therapy with GARDASIL and the patient''s death was unknown. Reported Cause(s) of Death: deceased.


VAERS ID: 785553 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Malignant atrophic papulosis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GT0095075131811GTM004348

Write-up: This spontaneous report was received from a physician via company representative regarding a female child of unknown age. The patient was not pregnant. The patient''s medical history and concomitant medications were not reported. Her concurrent condition included "Degos Disease". On an unknown date, the patient was vaccinated with a dose of GARDASIL (route, frequency, lot# and expiration date unknown) for prophylaxis. On an unknown date, the patient died. Cause of death was not reported. It was unknown if autopsy was performed. Despite there was no relation at all with the vaccination, several parents and doctors had recommended that the patient''s death occurred due to the vaccine administration. It was reported that the patient was not hospitalized. The reporting physician who was not the patient''s pediatrician mentioned that two patients (unspecified) who had to start vaccination scheme this week, desisted due to the rumors. The reporter assessed the event to be related with the GARDASIL. Reported Cause(s) of Death: unknown cause of death.


VAERS ID: 785768 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Disease progression, Leukaemia
SMQs:, Haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GR0095075131811GRC003149

Write-up: This spontaneous report was received from a Pediatrician, via a company representative, and refers to an adolescent female patient of unknown age (age reported as "12-13 years old"). No information was provided regarding the patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. In approximately 2013, (reported as "4-5 years ago"), the patient was vaccinated with her first dose of GARDASIL injection (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. In approximately 2013, (reported as "one month later"), the patient was diagnosed with leukaemia. In approximately 2015, (reported as "two years later"), the patient deceased due to progression of leukaemia. It was unknown if an autopsy was performed or not. The reporter considered the patient''s leukaemia and subsequent death as not related to GARDASIL. Upon internal review, the patient''s leukaemia was determined to be a medically significant event. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the GARDASIL vaccine and the reported event leukemia cannot be established. Information regarding time to onset, patient''s medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications, detailed clinical course are not provided and would be relevant for further assessment. Company Comment- No changes to the GARDASIL product safety information are warranted at this time. Merck and Co., Inc., known as MSD, continues to monitor the safety profile of the product. Reported Cause(s) of Death: progression of leukaemia.


VAERS ID: 786735 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Adverse reaction, Cerebrovascular accident, Death, Multiple sclerosis, Noninfective encephalitis, Seizure, Systemic lupus erythematosus
SMQs:, Systemic lupus erythematosus (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Optic nerve disorders (broad), Demyelination (narrow), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: JP0095075131811JPN005045

Write-up: This non-valid report has been received from other reporter who post in social media, via a vendor, concerning an unknown number of patients of unspecified age and gender. There was no information about the patients concurrent conditions, concomitant therapies or medical history provided. In 2013, the patients started therapy with GARDASIL (strength, dose, anatomical location, lot number, route of administration expiration date and indication were not reported). On unspecified dates, the patients experienced adverse reaction including seizures, brain inflammation, lupus, multiple sclerosis, strokes and death (death causes were unknown). At the time of report, the outcome of the patients regarding seizures, brain inflammation, lupus, multiple sclerosis, strokes was unknown and the causal relationship between all afore mentioned adverse events with GARDASIL was considered as related. Upon internal review seizures, brain inflammation, lupus, multiple sclerosis and strokes are considered medically significant events. Reported Cause(s) of Death: Death.


VAERS ID: 788622 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-11-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Disability, Paralysis
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GB0095075131811GBR010405

Write-up: This spontaneous report was received from a consumer via social media regarding multiple female patients of unknown age. The reporter posted on social media regarding an online article on which included information on documentary film. Patients'' historical condition/drugs, concurrent condition and concomitant drugs were unknown. On unknown dates, the patients were vaccinated with GARDASIL (strength, dose, frequency, lot# and expiration date were unknown) for preventing cervical cancer. On unknown dates, the patients experienced severe adverse reactions that includes disability, paralysis and even death. It was unknown, if autopsy was performed. Outcome of the events paralysis and adverse reaction was unknown. Causality assessment was not provided. Upon internal review, the events paralysis and death were determined to be medically significant. The event adverse reaction was considered to be serious due to disability. This is one of the two reports from the same reporter. Reported Cause(s) of Death: Death NOS.


VAERS ID: 792656 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DE0095075131812AUT009316

Write-up: This spontaneous report as received from an unspecified reporter, who found this case, refers to a female patient of unknown age. Her medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, frequency, route of administration, lot#, expiry unknown) for prophylaxis. It was reported by the Medicines Agency (MA) that on an unknown date, shortly after the vaccination, patient died due to unknown causes. It was unknown if an autopsy was performed or not. Causality assessment was not provided. This is one of the two reports received from the same reporter.; Sender''s Comments: DE-009507513-1812DEU008885:; Reported Cause(s) of Death: died.


Result pages: prev   23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=32&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166